Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto

Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto

US Patent 12171758 · Granted Dec 24, 2024

Estimated economic value: $27,093,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

JAK inhibitors containing a 4-membered heterocyclic amide2024
JAK kinase inhibitor compounds for treatment of respiratory disease2023
Fused imidazo-piperidine JAK inhibitors2023
JAK inhibitors containing a 4-membered heterocyclic amide2022
JAK kinase inhibitor compounds for treatment of respiratory disease2022
Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) pipera2022
Fused imidazo-piperidine JAK inhibitors2022
Ionic liquid shale inhibitor for drilling fluid and preparation method and appli2021
JAK inhibitors containing a 4-membered heterocyclic amide2021
Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazi2020
JAK inhibitors containing a 4-membered heterocyclic amide2020
JAK kinase inhibitor compounds for treatment of respiratory disease2020